Sequencing DNA is not an easy task at all, but scientist Kate Rubins managed to do it. She was even able to achieve the impressive milestone during her first space mission and while onboard of the International Space Station.
But Kate Rubins will be back in business soon, as she’ll be working on a cardiovascular experiment on the same space station. The experiment will add on an investigation that the scientist completed during her first space mission.
The launch is set for October
The scientist will return to the International Space Station on October 14, as the lift-off will occur from the Baikonur Cosmodrome in Kazakhstan. Rubins will travel onboard the Soyuz MS-17 spacecraft together with the two Roscosmos astronauts Sergey Ryzhikov and Sergey Kud-Sverchkov. The crew will be welcoming the arrival of NASA’s SpaceX Crew-1 mission, as well as the Boeing Orbital Flight Test-2.
The SpaceX Crew-1 mission (also known as USCV-1 or just Crew-1) will represent the first crewed operational flight of a Crew Dragon spacecraft. The Crew Dragon C207 spacecraft will be the one carrying NASA astronauts Michael Hopkins, Shannon Walker, and Victor Glover along with JAXA astronaut Soichi Noguchi. The mission will become the second crewed orbital flight of the Crew Dragon, pending the certification of the vehicle. The spacecraft will be mounted on a Falcon 9, and the lift-off will occur from the Kennedy Space Center, LC-39A.
The International Space Station serves as a home where astronauts and cosmonauts live. The space station is a unique science laboratory that orbits around the Earth, and several nations are collaborating in order to use the station. The satellite is a collaboration project between five space agencies: the notorious NASA (USA), ESA (the European Space Agency), JAXA (the Japan Aerospace Exploration Agency), CSA (the Canadian Space Agency), and Roscosmos (Russia).